SCHEMBL17391

SCHEMBL17391

CC(O)(c1ccc(N2CCN(S(=O)(=O)c3ccccc3)C[C@@H]2CC2CCOCC2)cc1)C(F)(F)F

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 9/20 0.77
GCK P35557 11/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15752 1.00 GCKR (0.77) GCKRGCK
SCHEMBL12078780 1.00 GCKR (0.77) GCKRGCK
SCHEMBL18385 1.00 GCKR (0.77) GCKRGCK
SCHEMBL16777 1.00 GCKR (0.77) GCKRGCK
SCHEMBL18513 1.00 GCKR (0.77) GCKRGCK
SCHEMBL12078987 1.00 GCKR (0.77) GCKRGCK
SCHEMBL12089331 0.91 GCKR (0.63) GCKRGCK
SCHEMBL12089328 0.91 GCKR (0.63) GCKRGCK
SCHEMBL12089329 0.91 GCKR (0.63) GCKRGCK
SCHEMBL18311 0.87 GCKR (1.00) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed